Halozyme Therapeutics
HALO
#2203
Rank
$6.91 B
Marketcap
$54.30
Share price
-0.82%
Change (1 day)
30.22%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : $1.66 B

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are $1.66 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$1.64 B-1.33%
2022-12-31$1.67 B84.22%
2021-12-31$0.90 B111.59%
2020-12-31$0.42 B-9.54%
2019-12-31$0.47 B147.76%
2018-12-31$0.19 B-38.58%
2017-12-31$0.31 B5.98%
2016-12-31$0.29 B111.83%
2015-12-31$0.13 B11.37%
2014-12-31$0.12 B2.33%
2013-12-31$0.12 B41.81%
2012-12-31$85.87 M56.54%
2011-12-31$54.85 M-22.73%
2010-12-31$70.99 M1.06%
2009-12-31$70.24 M14.81%
2008-12-31$61.18 M33.9%
2007-12-31$45.69 M98.58%
2006-12-31$23.01 M898.98%
2005-12-31$2.3 M45.84%
2004-12-31$1.57 M477.61%
2003-12-31$0.27 M-55.18%
2002-12-31$0.61 M18450.93%
2001-12-31$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.71 B-57.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.04 B 2,968.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.55 B 1,075.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$128.53 B 7,625.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.61 B 3,362.90%๐Ÿ‡ซ๐Ÿ‡ท France
$101.94 B 6,027.59%๐Ÿ‡บ๐Ÿ‡ธ USA